
  
    
      
        Introduction_NNP
        There_EX is_VBZ growing_VBG interest_NN in_IN intensive_JJ care_NN medicine_NN in_IN
        scoring_VBG systems_NNS for_IN measuring_VBG the_DT severity_NN of_IN illness_NN and_CC
        predicting_VBG outcome_NN in_IN critically_RB ill_JJ patients_NNS ._. Since_IN 1974_CD ,_,
        the_DT GCS_NNP [_NN 1_CD ]_NN has_VBZ been_VBN routinely_RB applied_VBN in_IN intensive_JJ care_NN
        units_NNS and_CC emergency_NN prehospital_NN settings_NNS ._. The_DT GCS_NNP provides_VBZ
        a_DT good_JJ basis_NN for_IN assessing_VBG the_DT depth_NN of_IN consciousness_NN and_CC
        coma_NN ._. This_DT scale_NN ,_, together_RB with_IN other_JJ neurological_JJ
        assessments_NNS [_NN 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ]_NN ,_, should_MD be_VB administered_VBN as_RB soon_RB
        as_IN possible_JJ in_IN emergency_NN situations_NNS ,_, and_CC may_MD be_VB repeated_VBN at_IN
        intervals_NNS ,_, especially_RB when_WRB neurological_JJ function_NN is_VBZ
        fluctuating_VBG [_NN 6_CD ]_NN ._.
        The_DT GCS_NNP was_VBD developed_VBN as_IN a_DT means_NN for_IN grading_VBG patients_NNS
        with_IN traumatic_JJ brain_NN injury_NN and_CC for_IN predicting_VBG their_PRP$
        chances_NNS of_IN neurological_JJ recovery_NN ._. Clinicians_NNP now_RB use_NN GCS_NNP as_IN
        the_DT only_RB neurological_JJ predictor_NN in_IN many_JJ prognostic_JJ systems_NNS ,_,
        such_JJ as_IN APACHE_NNP ,_, APACHE_NNP II_NNP ,_, APACHE_NNP III_NNP ,_, Acute_NNP Physiology_NNP
        Score_NN (_( APS_NNP )_) and_CC Simplified_NNP Acure_NNP Physiology_NNP Score_NN (_( SAPS_NNP )_) [_NN
        4_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ,_, 11_CD ]_NN ._. The_DT MEES_NNP is_VBZ a_DT descriptive_JJ scoring_VBG
        system_NN that_WDT includes_VBZ the_DT GCS_NNP assessment_NN [_NN 12_CD ]_NN ._. In_IN theory_NN ,_,
        the_DT prognostic_JJ APACHE_NNP II_NNP and_CC the_DT descriptive_JJ MEES_NNP scoring_VBG
        systems_NNS are_VBP more_RBR relevant_JJ to_TO prediction_NN of_IN outcome_NN in_IN
        critically_RB ill_JJ patients_NNS because_IN the_DT GCS_NNP assessment_NN is_VBZ
        included_VBN in_IN these_DT systems_NNS ._. On_IN the_DT basis_NN of_IN other_JJ parameters_NNS
        (_( arterial_NN pressure_NN ,_, heart_NN rate_NN ,_, respiratory_JJ rate_NN ,_,
        oxygenation_NN ,_, chronic_JJ health_NN points_NNS ,_, age_NN points_NNS )_) ,_, the_DT MEES_NNP
        (_( descriptive_JJ )_) and_CC APACHE_NNP II_NNP (_( prognostic_JJ )_) systems_NNS should_MD be_VB
        better_JJR than_IN the_DT GCS_NNP at_IN predicting_VBG outcomes_NNS ._.
        The_DT purpose_NN of_IN the_DT present_JJ study_NN was_VBD to_TO assess_VB the_DT value_NN
        of_IN scoring_VBG systems_NNS in_IN predicting_VBG outcome_NN in_IN nontraumatic_JJ
        coma_NN patients_NNS and_CC to_TO evaluate_VB the_DT importance_NN of_IN mental_JJ
        status_NN measurement_NN in_IN relation_NN to_TO outcome_NN ._.
      
      
        Patients_NNS and_CC methods_NNS
        This_DT prospective_JJ study_NN was_VBD undertaken_VBN over_IN a_DT 2_CD -_: year_NN
        period_NN ,_, and_CC included_VBD 286_CD consecutive_JJ patients_NNS hospitalized_VBN
        for_IN nontraumatic_JJ coma_NN ._. The_DT inclusion_NN criteria_NNS were_VBD GCS_NNP ≤_NN 9_CD ,_,
        and_CC specific_JJ medical_JJ diagnoses_NNS as_IN follows_VBZ :_: hypoxic_JJ or_CC
        ischaemic_JJ injury_NN ;_: focal_JJ cerebral_JJ injury_NN ;_: general_JJ cerebral_JJ
        injury_NN ;_: metabolic_JJ or_CC septic_JJ encephalopathy_NN ;_: and_CC
        drug-induced_JJ coma_NN or_CC toxic_JJ injury_NN ,_, including_VBG drug_NN overdose_NN
        and_CC coma_NN persisting_VBG 24_CD h_NN after_IN discontinuation_NN of_IN toxic_JJ
        substances_NNS ._.
        In_IN the_DT prehospital_NN setting_VBG ,_, postintervention_NN values_NNS
        (_( before_IN admission_NN of_IN the_DT patient_NN to_TO hospital_NN )_) for_IN the_DT MEES_NNP
        and_CC GCS_NNP scales_NNS were_VBD measured_VBN in_IN each_DT patient_NN (_( Table_NNP 1_LS )_) ._. The_DT
        APACHE_NNP II_NNP score_NN was_VBD recorded_VBN on_IN the_DT day_NN of_IN admission_NN to_TO
        hospital_NN [_NN 7_CD ]_NN ._.
        The_DT sensitivity_NN ,_, specificity_NN and_CC predictive_JJ power_NN of_IN
        each_DT cutoff_NN point_NN were_VBD calculated_VBN from_IN the_DT two-by-two_JJ table_NN
        in_IN SPSS_NNP for_IN Windows_NNP (_( MIcrosoft_NNP ,_, Washington_NNP ,_, USA_NNP )_) for_IN APACHE_NNP
        II_NNP ,_, MEES_NNP and_CC GCS_NNP [_NN 14_CD ]_NN ._. The_DT Youden_NNP index_NN was_VBD also_RB used_VBN to_TO
        determine_VB the_DT best_JJS cutoff_NN points_NNS (_( the_DT higher_JJR the_DT index_NN ,_, the_DT
        better_VB the_DT prediction_NN at_IN the_DT cutoff_NN point_NN )_) [_NN 15_CD ]_NN ._.
        Percentages_NNP of_IN correct_JJ predictions_NNS of_IN mortality_NN were_VBD
        obtained_VBN at_IN these_DT same_JJ cutoff_NN points_NNS ._. For_IN each_DT score_NN ,_, ROC_NNP
        curves_NNS were_VBD obtained_VBN [_NN 16_CD ,_, 17_CD ]_NN ._. The_DT ROC_NNP curve_NN depicts_VBZ the_DT
        relation_NN between_IN true-positive_JJ results_NNS (_( number_NN of_IN predicted_VBD
        deaths_NNS among_IN those_DT who_WP actually_RB died_VBD )_) and_CC false-positive_JJ
        results_NNS (_( number_NN of_IN predicted_VBD deaths_NNS among_IN those_DT who_WP
        actually_RB survived_VBD )_) for_IN each_DT score_NN ._. The_DT greater_JJR the_DT area_NN
        under_IN ROC_NNP curve_NN ,_, the_DT better_VB the_DT scoring_VBG system_NN ._. The_DT ROC_NNP
        curve_NN was_VBD calculated_VBN using_VBG the_DT Systat_NNP software_NN (_( Systat_NNP Inc_NNP ,_,
        Evanstan_NNP ,_, IL_NNP ,_, USA_NNP )_) ._. The_DT outcome_NN predictions_NNS data_NNS were_VBD
        analyzed_VBN using_VBG McNemar_NNP 's_POS test_NN ._. The_DT compara-sions_JJ of_IN the_DT
        areas_NNS under_IN the_DT ROC_NNP curves_NNS and_CC the_DT analyses_NNS of_IN the_DT
        differences_NNS of_IN Youden_NNP index_NN were_VBD performed_VBN using_VBG the_DT method_NN
        described_VBN by_IN Hanley_NNP and_CC McNeil_NNP [_NN 16_CD ,_, 17_CD ]_NN ._. 
        P_NN <_NN 0_CD ._. 05_CD was_VBD considered_VBN
        statistically_RB significant_JJ ._. Values_NNP are_VBP expressed_VBN as_IN mean_NN ±_NN
        standard_JJ error_NN ._.
      
      
        Results_NNS
        Of_IN the_DT 286_CD patients_NNS included_VBN in_IN the_DT present_JJ study_NN ,_, 80_CD
        died_VBD in_IN hospital_NN ._. The_DT patients_NNS who_WP died_VBD were_VBD older_JJR than_IN
        those_DT who_WP survived_VBD (_( 66_CD ._. 8_CD ±_NN 11_CD ._. 1_LS years_NNS versus_CC 46_CD ._. 1_LS ±_NN 15_CD ._. 4_LS
        years_NNS ;_: 
        P_NN <_NN 0_CD ._. 05_CD )_) and_CC a_DT higher_JJR proportion_NN
        were_VBD males_NNS (_( 61_CD %_NN )_) ._. The_DT scores_NNS for_IN all_DT three_CD scales_NNS were_VBD
        better_JJR in_IN survivors_NNS than_IN in_IN those_DT who_WP died_VBD (_( APACHE_NNP II_NNP ,_, 29_CD ._. 8_CD
        ±_NN 5_CD ._. 3_CD versus_CC 20_CD ._. 8_CD ±_NN 2_CD ._. 8_CD [_NN 
        P_NN <_NN 0_CD ._. 05_CD ]_NN ;_: MEES_NNP ,_, 16_CD ._. 2_LS ±_NN 2_CD ._. 5_CD versus_CC
        20_CD ._. 1_LS ±_NN 2_CD ._. 7_CD [_NN 
        P_NN <_NN 0_CD ._. 05_CD ]_NN ;_: GCS_NNP ,_, 6_CD ._. 2_CD ±_NN 2_CD ._. 1_CD versus_CC
        8_CD ._. 1_CD ±_NN 1_CD ._. 2_CD [_NN 
        P_NN <_NN 0_CD ._. 05_CD ]_NN )_) ._. The_DT distributions_NNS of_IN
        APACHE_NNP II_NNP ,_, MEES_NNP and_CC GCS_NNP scores_NNS are_VBP given_VBN in_IN Fig_NNP ._. 1_LS ._.
        Hypoxic_NNP or_CC ischaemic_JJ injury_NN was_VBD the_DT cause_NN of_IN coma_NN in_IN 62_CD
        (_( 21_CD ._. 7_CD %_NN )_) ,_, metabolic_JJ or_CC septic_JJ coma_NN occurred_VBD in_IN 45_CD (_( 15_CD ._. 7_CD %_NN )_) ,_,
        focal_JJ cerebral_JJ lesions_NNS occurred_VBD in_IN 56_CD (_( 19_CD ._. 6_CD %_NN )_) ,_, generalized_JJ
        cerebral_JJ lesions_NNS occurred_VBD in_IN 22_CD (_( 7_CD ._. 7_CD %_NN )_) ,_, and_CC drug-induced_JJ or_CC
        toxic_JJ coma_NN occurred_VBD in_IN 101_CD (_( 35_CD ._. 3_LS %_NN )_) ._. Mortality_NNP data_NNS are_VBP
        given_VBN in_IN Table_NNP 2_CD ._.
        Table_NNP 3_CD provides_VBZ data_NNS for_IN sensitivity_NN ,_, specificity_NN and_CC
        correct_JJ predictions_NNS of_IN outcome_NN at_IN the_DT cutoff_NN points_NNS that_WDT
        gave_VBD the_DT best_JJS Youden_NNP index_NN ._. The_DT three_CD scores_NNS were_VBD also_RB
        compared_VBN by_IN drawing_VBG ROC_NNP curves_NNS in_IN order_NN to_TO avoid_VB fixing_VBG
        arbitrary_JJ cutoff_NN points_NNS (_( Fig_NNP ._. 2_LS )_) ._. There_EX were_VBD no_DT
        statistically_RB significant_JJ differences_NNS in_IN the_DT correct_JJ
        prediction_NN of_IN outcome_NN ,_, Youden_NNP index_NN or_CC area_NN under_IN the_DT ROC_NNP
        curve_NN among_IN APACHE_NNP II_NNP ,_, MEES_NNP and_CC GCS_NNP for_IN hospital_NN
        mortality_NN ._.
      
      
        Discussion_NNP
        Subjective_NNP evaluations_NNS of_IN clinical_JJ status_NN by_IN individual_JJ
        clinicians_NNS may_MD differ_VB in_IN terminology_NN ,_, and_CC even_RB in_IN
        measurement_NN of_IN the_DT severity_NN of_IN illness_NN ._. Hence_RB ,_, various_JJ
        descriptive_JJ and_CC prognostic_JJ evaluation_NN scales_NNS (_( scoring_VBG
        systems_NNS )_) have_VBP been_VBN developed_VBN during_IN the_DT past_JJ three_CD decades_NNS ._.
        Objective_NNP evaluation_NN of_IN clinical_JJ status_NN would_MD facilitate_VB
        comparison_NN of_IN methods_NNS ,_, staff_NN ,_, clinical_JJ centres_NNS and_CC studies_NNS
        [_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD ,_, 7_CD ,_, 8_CD ,_, 13_CD ,_, 14_CD ]_NN ._. The_DT need_NN for_IN such_JJ
        evaluation_NN scales_NNS is_VBZ particularly_RB evident_JJ in_IN coma_NN patients_NNS ,_,
        and_CC even_RB more_RBR so_RB in_IN patients_NNS with_IN alterations_NNS in_IN
        consciousness_NN ._. The_DT aim_NN of_IN research_NN in_IN this_DT area_NN is_VBZ to_TO
        obtain_VB a_DT reliable_JJ and_CC sensitive_JJ scale_NN ._.
        In_IN 1974_CD ,_, such_JJ research_NN resulted_VBD in_IN the_DT GCS_NNP [_NN 1_CD ,_, 6_CD ]_NN ._.
        Since_IN this_DT scale_NN was_VBD reported_VBN ,_, numerous_JJ studies_NNS have_VBP
        examined_VBN its_PRP$ value_NN in_IN assessing_VBG clinical_JJ status_NN and_CC
        prognosis_NN ._. Initially_RB ,_, the_DT scale_NN was_VBD used_VBN in_IN patients_NNS with_IN
        head_NN injury_NN [_NN 6_CD ]_NN ,_, but_CC later_RB it_PRP became_VBD widely_RB used_VBN in_IN
        evaluating_VBG central_JJ nervous_JJ system_NN lesions_NNS and_CC state_NN of_IN
        consciousness_NN ._.
        With_IN the_DT development_NN of_IN emergency_NN medicine_NN ,_, a_DT need_NN arose_VBD
        for_IN evaluation_NN scales_NNS that_WDT would_MD provide_VB rapid_JJ triage_NN and_CC
        objective_NN status_NN assessment_NN ._. On_IN the_DT other_JJ hand_NN ,_, a_DT
        prehospital_NN evaluation_NN scale_NN would_MD be_VB optimal_NN if_IN (_( apart_RB
        from_IN being_VBG descriptive_JJ )_) it_PRP had_VBD a_DT prognostic_JJ component_NN ,_, and_CC
        would_MD therefore_RB be_VB applicable_JJ to_TO hospital-based_JJ observation_NN
        of_IN the_DT patient_NN ._. Among_IN the_DT various_JJ scales_NNS ,_, MEES_NNP has_VBZ
        attracted_VBN attention_NN because_IN of_IN its_PRP$ applicability_NN in_IN trauma_NN
        and_CC illness_NN [_NN 12_CD ]_NN ._. Cho_NNP and_CC Wang_NNP [_NN 14_CD ]_NN concluded_VBD that_IN ,_, for_IN
        head-injured_JJ patients_NNS ,_, the_DT GCS_NNP has_VBZ good_JJ predictive_JJ value_NN
        for_IN hospital_NN mortality_NN in_IN comparison_NN with_IN other_JJ evaluation_NN
        scales_NNS ._. The_DT latter_JJ scale_NN has_VBZ also_RB attracted_VBN attention_NN
        because_IN of_IN its_PRP$ simplicity_NN ._.
        In_IN view_NN of_IN the_DT experience_NN with_IN these_DT scales_NNS in_IN traumatic_JJ
        coma_NN ,_, we_PRP conducted_VBD a_DT comparative_JJ study_NN in_IN nontraumatic_JJ
        coma_NN ._. The_DT need_NN for_IN accurate_JJ prediction_NN of_IN mortality_NN in_IN
        non-traumatic_JJ coma_NN by_IN GCS_NNP was_VBD identified_VBN by_IN Plum_NNP and_CC Levy_NNP
        in_IN 1978_CD [_NN 18_CD ]_NN ._. In_IN their_PRP$ comparison_NN of_IN GCS_NNP with_IN other_JJ
        neurological_JJ tests_NNS ,_, Levy_NNP 
        et_CC al_NN [_NN 19_CD ]_NN demonstrated_VBN that_IN the_DT GCS_NNP
        has_VBZ good_JJ predictive_JJ value_NN ._. A_DT number_NN of_IN studies_NNS [_NN 13_CD ,_, 20_CD ,_,
        21_CD ,_, 22_CD ,_, 23_CD ,_, 24_CD ,_, 25_CD ,_, 26_CD ]_NN have_VBP emphasized_VBN the_DT importance_NN of_IN
        aetiology_NN ,_, which_WDT ,_, together_RB with_IN GCS_NNP ,_, represents_VBZ a_DT good_JJ
        combination_NN for_IN better_JJR prediction_NN of_IN mortality_NN ._. In_IN our_PRP$
        work_NN ,_, we_PRP have_VBP also_RB observed_VBN the_DT prognostic_JJ value_NN of_IN
        individual_JJ elements_NNS of_IN the_DT electrocardiogram_NN in_IN coma_NN
        following_VBG cerebrovascu-lar_JJ accident_NN and_CC organophosphate_NN
        poisoning_NN ._. Romera_NNP [_NN 27_CD ]_NN demonstrated_VBN that_IN GCS_NNP score_NN
        correlates_NNS with_IN APACHE_NNP II_NNP score_NN in_IN patients_NNS who_WP have_VBP
        suffered_VBN a_DT cerebrovascular_NN accident_NN ;_: also_RB ,_, the_DT former_NN is_VBZ
        simpler_JJR and_CC has_VBZ fewer_JJR parameters_NNS ._. It_PRP was_VBD concluded_VBN that_IN GCS_NNP
        was_VBD ,_, because_IN of_IN its_PRP$ simplicity_NN and_CC rapidity_NN ,_, a_DT better_JJR scale_NN
        than_IN the_DT Simplified_NNP Acute_NNP Physiology_NNP Score_NN for_IN prediction_NN
        of_IN mortality_NN in_IN patients_NNS with_IN cerebroventricular_NN accident_NN ._.
        Kriger_NNP 
        et_CC al_NN [_NN 28_CD ]_NN identified_VBD a_DT correlation_NN
        between_IN intracranial_NN pressure_NN ,_, analyses_NNS of_IN evoked_JJ
        potentials_NNS and_CC GCS_NNP score_NN ,_, regardless_RB of_IN aetiology_NN of_IN coma_NN ._.
        Those_DT investigators_NNS also_RB concluded_VBD that_IN GCS_NNP is_VBZ a_DT good_JJ
        prognostication_NN tool_NN ,_, as_IN compared_VBN with_IN other_JJ ,_, more_RBR
        complicated_JJ methods_NNS ._.
        In_IN the_DT present_JJ study_NN ,_, coma_NN patients_NNS were_VBD grouped_VBN on_IN the_DT
        basis_NN of_IN aetiology_NN ,_, according_VBG to_TO the_DT method_NN of_IN Sacco_NNP 
        et_CC al_NN [_NN 13_CD ]_NN ._. No_DT statistically_RB
        significant_JJ differences_NNS in_IN accuracy_NN of_IN prognosis_NN prediction_NN
        were_VBD identified_VBN for_IN the_DT three_CD scales_NNS assessed_VBN ._. For_IN
        prehospital_NN work_NN ,_, this_DT finding_VBG is_VBZ important_JJ because_IN it_PRP
        shows_VBZ that_IN GCS_NNP does_VBZ not_RB deviate_NN significantly_RB either_CC from_IN
        the_DT MEES_NNP scale_NN (_( which_WDT has_VBZ more_JJR parameters_NNS )_) or_CC from_IN the_DT
        APACHE_NNP II_NNP scale_NN (_( which_WDT is_VBZ measured_VBN in_IN hospital_NN )_) ._. GCS_NNP has_VBZ
        important_JJ advantages_NNS over_IN other_JJ scales_NNS ,_, because_IN it_PRP enables_VBZ
        rapid_JJ evaluation_NN of_IN status_NN and_CC may_MD direct_VB necessary_JJ
        interventions_NNS ._. Furthermore_RB ,_, it_PRP is_VBZ possible_JJ to_TO observe_VB
        continuously_RB the_DT state_NN of_IN consciousness_NN ,_, and_CC to_TO identify_VB
        eventual_JJ improvement_NN (_( indicating_VBG efficacy_NN of_IN therapy_NN )_) or_CC
        deterioration_NN ._. GCS_NNP is_VBZ widespread_JJ and_CC clinicians_NNS are_VBP
        familiar_JJ with_IN it_PRP ._. This_DT scale_NN therefore_RB facilitates_NNS good_JJ
        '_POS clinical_JJ communication_NN '_'' between_IN prehospital_NN work_NN and_CC
        further_JJ hospital_NN procedures_NNS and_CC treatments_NNS ._.
        The_DT GCS_NNP values_NNS determined_VBN before_IN hospitalization_NN of_IN the_DT
        patients_NNS and_CC the_DT APACHE_NNP II_NNP scores_NNS determined_VBN on_IN the_DT first_JJ
        day_NN of_IN hospitalization_NN enabled_VBD us_PRP to_TO compare_VB descriptive_JJ
        and_CC prognostic_JJ scales_NNS directly_RB ._. We_PRP compared_VBD the_DT prognostic_JJ
        value_NN of_IN postintervention_NN prehospital_NN values_NNS of_IN GCS_NNP and_CC
        hospital_NN values_NNS of_IN APACHE_NNP II_NNP ._. We_PRP found_VBD that_IN the_DT prehospital_NN
        GCS_NNP assessment_NN was_VBD as_IN good_JJ a_DT predictor_NN of_IN mortality_NN as_IN was_VBD
        the_DT APACHE_NNP II_NNP score_NN ,_, as_IN measured_VBN in_IN the_DT hospital_NN ._. The_DT GCS_NNP
        is_VBZ well_RB established_VBN ,_, and_CC its_PRP$ simple_JJ application_NN before_IN
        admission_NN to_TO hospital_NN and_CC during_IN hospital_NN treatment_NN
        facilitates_NNS continuous_JJ evaluation_NN of_IN the_DT patient_NN 's_POS state_NN
        and_CC allows_VBZ prognostic_JJ evaluation_NN in_IN non-traumatic_JJ coma_NN ._.
      
    
  
